MedPath

SANDOZ ANUZINC HC PLUS

SANDOZ ANUZINC HC PLUS

Discontinued
DIN Number

02247692

Drug Class

Human

Market Date

Jan 20, 2004

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02247692
AIG Number0314223001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C05AA01 HYDROCORTISONE
Product Specifications
Dosage FormOintment
Route of AdministrationTopical ,  Rectal
AHFS Classification84:06.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

HYDROCORTISONE ACETATEActive
Strength: 5 MG / G
Monograph: HYDROCORTISONE ACETATE
PRAMOXINE HYDROCHLORIDEActive
Strength: 10 MG / G
Monograph: PRAMOXINE HYDROCHLORIDE
ZINC SULFATEActive
Strength: 5 MG / G
Monograph: ZINC SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.